Cancer Immunotherapy
-
{
- All
- News
-
Jurassic Park Star Sam Neill Is Cancer-Free After Chemotherapy Failed; How CAR T-Cell Therapy Worked
- Friday May 1, 2026
- Health | Written by Sambhav Kumar
Sam Neill had been undergoing chemotherapy for years, but the treatment eventually became ineffective. At one point, he described his condition as critical.
-
www.ndtv.com
-
Which Cancers Does Keytruda Work On? Apollo Oncologists Explain Effectiveness
- Saturday April 18, 2026
- Health | Written by Debosmita Ghosh
The Drug Controller General of India (DCGI) has approved Keytruda for multiple cancer types. As of recent approvals, it covers 14 indications across eight tumour types.
-
www.ndtv.com
-
High Cost, Limited Access: How Counterfeit Keytruda Market Puts Cancer Patients At Risk
- Tuesday April 21, 2026
- Health | Written by Tanushka Dutta
Keytruda, developed by Merck & Co., belongs to a class of drugs known as immune checkpoint inhibitors, which help the immune system identify and attack cancer cells.
-
www.ndtv.com
-
Chemotherapy Vs Immunotherapy: What's The Difference In Cancer Care?
- Tuesday April 14, 2026
- Health | Written by Sambhav Kumar
Immunotherapy is generally associated with fewer and milder side effects compared to chemotherapy. Many patients are able to continue their routine activities during treatment.
-
www.ndtv.com
-
Oncologists Explain Why They Prescribe Keytruda To Cancer Patients, When And How It Works
- Tuesday April 14, 2026
- Health | Written by Debosmita Ghosh
Keytruda is approved by the Drug Controller General of India (DCGI) for multiple cancer types. As of recent approvals, it covers 14 indications across eight tumour types.
-
www.ndtv.com
-
What Is Keytruda And Why Is Everyone Talking About It In India's Cancer Fight?
- Monday April 13, 2026
- Health | Written by Debosmita Ghosh
In India, Keytruda is approved by the Drug Controller General of India (DCGI) for multiple cancer types. As of recent approvals, it covers 14 indications across eight tumour types.
-
www.ndtv.com
-
From Surgery To Immunotherapy: Doctor Explains Advances In Oral Cancer Treatment
- Friday April 3, 2026
- Health | Written by Sambhav Kumar
A major shift in recent years is the use of immunotherapy earlier in the treatment process, even before surgery. This is known as neoadjuvant immunotherapy.
-
www.ndtv.com
-
Breakthrough Brain Cancer Therapy Shows Dramatic Tumour Shrinking In 5 Days In Early Trial
- Tuesday March 31, 2026
- Health | Written by Sambhav Kumar
CAR-T therapy works by taking a patient's immune cells, modifying them in a lab to better recognise cancer, and then infusing them back into the body.
-
www.ndtv.com
-
Woman With Stage-3 Colorectal Cancer Recovers In Only 4 Months, Thanks To This New Therapy
- Friday March 6, 2026
- Feature | Edited by Abhinav Singh
Mrinali Dhembla, 27, diagnosed with stage-3 colorectal cancer and Lynch syndrome, recovers rapidly after receiving a dual immunotherapy regimen.
-
www.ndtv.com
-
When Stomach Pain Isn't Just Acidity: The Red Flags In Dipika Kakar's Recent Diagnosis
- Monday February 23, 2026
- Health | Written by Rupashi Chhabra
Television actress Dipika Kakar's recent stomach pain revealed a 13 mm cyst after her liver cancer treatment. Here are the red flags that show stomach pain can be more than acidity, and why you need to be aware of it.
-
www.ndtv.com
-
Jurassic Park Star Sam Neill Is Cancer-Free After Chemotherapy Failed; How CAR T-Cell Therapy Worked
- Friday May 1, 2026
- Health | Written by Sambhav Kumar
Sam Neill had been undergoing chemotherapy for years, but the treatment eventually became ineffective. At one point, he described his condition as critical.
-
www.ndtv.com
-
Which Cancers Does Keytruda Work On? Apollo Oncologists Explain Effectiveness
- Saturday April 18, 2026
- Health | Written by Debosmita Ghosh
The Drug Controller General of India (DCGI) has approved Keytruda for multiple cancer types. As of recent approvals, it covers 14 indications across eight tumour types.
-
www.ndtv.com
-
High Cost, Limited Access: How Counterfeit Keytruda Market Puts Cancer Patients At Risk
- Tuesday April 21, 2026
- Health | Written by Tanushka Dutta
Keytruda, developed by Merck & Co., belongs to a class of drugs known as immune checkpoint inhibitors, which help the immune system identify and attack cancer cells.
-
www.ndtv.com
-
Chemotherapy Vs Immunotherapy: What's The Difference In Cancer Care?
- Tuesday April 14, 2026
- Health | Written by Sambhav Kumar
Immunotherapy is generally associated with fewer and milder side effects compared to chemotherapy. Many patients are able to continue their routine activities during treatment.
-
www.ndtv.com
-
Oncologists Explain Why They Prescribe Keytruda To Cancer Patients, When And How It Works
- Tuesday April 14, 2026
- Health | Written by Debosmita Ghosh
Keytruda is approved by the Drug Controller General of India (DCGI) for multiple cancer types. As of recent approvals, it covers 14 indications across eight tumour types.
-
www.ndtv.com
-
What Is Keytruda And Why Is Everyone Talking About It In India's Cancer Fight?
- Monday April 13, 2026
- Health | Written by Debosmita Ghosh
In India, Keytruda is approved by the Drug Controller General of India (DCGI) for multiple cancer types. As of recent approvals, it covers 14 indications across eight tumour types.
-
www.ndtv.com
-
From Surgery To Immunotherapy: Doctor Explains Advances In Oral Cancer Treatment
- Friday April 3, 2026
- Health | Written by Sambhav Kumar
A major shift in recent years is the use of immunotherapy earlier in the treatment process, even before surgery. This is known as neoadjuvant immunotherapy.
-
www.ndtv.com
-
Breakthrough Brain Cancer Therapy Shows Dramatic Tumour Shrinking In 5 Days In Early Trial
- Tuesday March 31, 2026
- Health | Written by Sambhav Kumar
CAR-T therapy works by taking a patient's immune cells, modifying them in a lab to better recognise cancer, and then infusing them back into the body.
-
www.ndtv.com
-
Woman With Stage-3 Colorectal Cancer Recovers In Only 4 Months, Thanks To This New Therapy
- Friday March 6, 2026
- Feature | Edited by Abhinav Singh
Mrinali Dhembla, 27, diagnosed with stage-3 colorectal cancer and Lynch syndrome, recovers rapidly after receiving a dual immunotherapy regimen.
-
www.ndtv.com
-
When Stomach Pain Isn't Just Acidity: The Red Flags In Dipika Kakar's Recent Diagnosis
- Monday February 23, 2026
- Health | Written by Rupashi Chhabra
Television actress Dipika Kakar's recent stomach pain revealed a 13 mm cyst after her liver cancer treatment. Here are the red flags that show stomach pain can be more than acidity, and why you need to be aware of it.
-
www.ndtv.com